Immunomodulatory Agents Combat Multidrug-Resistant Tuberculosis by Improving Antimicrobial Immunity

BACKGROUND: Multidrug-resistant (MDR) tuberculosis has low treatment success rates, and new treatment strategies are needed. We explored whether treatment with active vitamin D(3) (vitD) and phenylbutyrate (PBA) could improve conventional chemotherapy by enhancing immune-mediated eradication of Myco...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:J Infect Dis
Main Authors: Rao Muvva, Jagadeeswara, Ahmed, Sultan, Rekha, Rokeya Sultana, Kalsum, Sadaf, Groenheit, Ramona, Schön, Thomas, Agerberth, Birgitta, Bergman, Peter, Brighenti, Susanna
Formato: Artigo
Idioma:Inglês
Publicado: Oxford University Press 2021
Assuntos:
Major Articles and Brief Reports
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC8280489/
https://ncbi.nlm.nih.gov/pubmed/33606878
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/infdis/jiab100
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares